Voquezna Will Be a New Treatment for H. pylori

August 2022

Voquezna Dual Pak and Triple Pak will be new Rx combos for H. pylori...an infection in the stomach that can lead to ulcers.

These combo products contain vonoprazan...the first “potassium-competitive acid blocker (PCAB).” Think of vonoprazan as a “fancy” PPI (omeprazole, etc)...it works to reduce acid a bit differently.

Help clarify Rxs that just say “Voquezna.” The Dual Pak has vonoprazan and amoxicillin...the Triple Pak adds clarithromycin.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Cultural Awareness Help Investigate Whether a Med is Derived From Animals
Heart Failure Minimize Mishaps With Heart Failure Meds
Gastroenterology Voquezna Will Be a New Treatment for H. pylori
Immunizations Keep Adolescents on Track with Immunizations
Recalls Work as a Team to Handle Drug Recalls
Supplements Sort Through Supplements for Osteoarthritis
Communication Promote Respect Among Colleagues
Oral Health Be Familiar With Treatments for Canker and Cold Sores
Statins Help Patients Stick With a Statin

Voquezna Will Be a New Treatment for H. pylori

Practical advice for a better career, with unlimited access to CE

Table of Contents